Bausch Health Companies (BHC) Stock
Bausch Health Companies (BHC) closed at $8.35 on Nov 13, 2026; its Tenet Score is 50 of 100 against 409 Healthcare peers.
26 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $8.35
- Nov 13, 2026
- Market cap
- $3.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 4.33 – 9.04
- low → high
- Tenet Score
- 50/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Bausch Health Companies Inc scores 50/100. Mixed. Strongest on value, financial health is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ~ Piotroski F-Score
- ✕ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ✕ Income & Dividend Safety
13F flows & insider trades land here.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatol…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Indivior Pharmaceuticals Inc.INDV | 51 | $3.5B |
| Supernus Inc.SUPN | 47 | $3.5B |
| Acadia Pharmaceuticals IncACAD | 64 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.2B |
| Ideaya Biosciences IncIDYA | 62 | $3.1B |
| Xeris Biopharma Holdings IncXERS | 44 | $3.0B |
| Adma Biologics IncADMA | 67 | $3.0B |
| Denali Therapeutics IncDNLI | 53 | $3.0B |
| Vericel CorpVCEL | 59 | $2.9B |
| Xencor IncXNCR | 41 | $2.8B |
Common questions
What sector and industry is Bausch Health Companies in?
Bausch Health Companies is in the Healthcare sector and the Drugs industry.
What is Bausch Health Companies' Tenet Score?
Bausch Health Companies' Tenet Score is 50 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




